[Recommendations] The Political Leadership and International Collaboration Needed to Adv ...>>
[Activity Report] Opinions Regarding the Proposed “Action Policy for Ensuring a Stable S ...>>
[Activity Report] “AMR & JAPAN’S G7 PRESIDENCY: A Call for Pull Incentives to Drive ...>>
[In the Media] Commencement of the 109th HGPI Seminar “The Clinical Treatment of Infecti ...>>
[Event Report] The 109th HGPI Seminar “The Clinical Treatment of Infectious Diseases in ...>>
[In the Media] The 9th NIKKEI FT Communicable Diseases Conference – Antibiotic Developme ...>>
[Activity Report] The 9th Nikkei FT Communicable Diseases Conference – The AMR Consortiu ...>>
[Lecture Report] The 9th NIKKEI FT Communicable Diseases Conference ― Tokyo Communicable ...>>


![[Event Report] The 49th Special Breakfast Meeting – Push and Pull Incentives to Address AMR: The Experience of CARB-X and the potential for Public-Private Partnerships in Global Health (September 21, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/sbm-49-1-top_1F7A0978_web.jpg)
![[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-27.jpg)
![[Event Report] AMR Alliance Japan Symposium “Achieving Collaboration Among Hospitals and Clinics within AMR Countermeasures for Antimicrobial Stewardship -Facilitating collaboration that is based on data-” (September 14, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-20220914-1-top.jpg)
![[Lecture Report] The Pharmaceutical Manufacturers Association of Japan Media Forum – “Preparing for Antimicrobial Resistance (AMR) Awareness Month” (November 8, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-196-top.jpg)
